title: [Bisoprolol: opportunities in the treatment of hypertension].
abstract: Bisoprolol (bisoprolol fumarate) - -cardioselective blocker, does not possess intrinsic sympathomimetic and membrane stabilizing activity. The main indications for bisoprolol are arterial hypertension (AH) and heart failure. This article provides an overview of the literature on the potential uses of bisoprolol in the treatment of hypertension. The features of the pharmacokinetics of the drug. The data on the effectiveness of bisoprolol in hypertension and tolerability in patients with concomitant disorders: diabetes, chronic obstructive pulmonary disease, peripheral atherosclerosis. Proofs of the high efficiency of antianginal bisoprola and justified the use of the drug in patients with hypertension and coronary heart disease. The capabilities of bisoprolol in the perioperative correction of hypertension. The data and pharmacoeconomic properties of bisoprolol generic counterparts.
authors: L O
authors: LO
authors: Minushkina
mesh_terms: D058671:Adrenergic beta-1 Receptor Antagonists / Q000008:administration & dosage / Q000009:adverse effects / Q000493:pharmacokinetics; D001682:Biological Availability; D017298:Bisoprolol / Q000008:administration & dosage / Q000009:adverse effects / Q000493:pharmacokinetics; D015897:Comorbidity; D003327:Coronary Disease / Q000150:complications / Q000188:drug therapy / Q000503:physiopathology; D016568:Drugs, Generic / Q000191:economics / Q000493:pharmacokinetics; D006333:Heart Failure / Q000150:complications / Q000188:drug therapy / Q000503:physiopathology; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000188:drug therapy / Q000503:physiopathology; D019990:Perioperative Care / Q000379:methods; D013810:Therapeutic Equivalency; D016896:Treatment Outcome
chemical_list: D058671:Adrenergic beta-1 Receptor Antagonists; D016568:Drugs, Generic; D017298:Bisoprolol